Best Option for T-Bet Staining in Human

Charite Strasse 1
Deutsches Rheuma-Forschungszentrum
Research Scientist

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

ThermoFischer Scientific

Product Name:

T-bet Monoclonal Antibody (eBio4B10 (4B10)), eFluor™ 660, eBioscience™

Catalog Number:

50-5825-82

Clone Number:

eBio4B10 (4B10)

Info:Supplier Page View Product Specs

Browse Similar Products: T-Bet Antibodies

Our research aims to understand how some CD4 T cells become autoreactive in melanoma patients treated with check point inhibitors. In this experiment, we tested the expression of the typical T helper type 1 transcription factor T-BET in CD4 T cells with an anti-TBET eFluor660 antibody.

Experimental Design and Results Summary

Applications

Flow Cytometry

Sample

Stimulated (PMA+Iono) healthy donor's PBMCs

Primary Incubation

Washed twice in PBS and incubated with L/D fixable aqua dye 20 min at 4°C, then washed twice in PBS.

Blocking Agent

2.4G2

Secondary Incubation

Surface staining with anti-CD4 PE dazzle594, CD3 BUV395, CD45RO BUV737 etc., 30' at 4°C, in the dark, in BD Horizon™ Brilliant Stain Buffer.

Tertiary Incubation

Cells were fixed and permeabilized with commercial kit (FoxpP3 transcription factor kit, eBioscience) for 30 min at 4°C with fixative, 15 min at 4°C with permeabilization buffer, and stained with anti-IFN-g PE-Cy7 and anti-T-BET eFluor660 at 1/800 in permeabilization buffer.

Detection

red laser on Symphony cytometer

Results Summary

The antibody identifies clearly T-BET on stimulated CD4 T cells counterstained with IFN-g. Of note, the staining also works on unstimulated cells.

DOI or PMID #

Additional Notes

Image Gallery

Summary

The Good

Gives good separation at relatively high dilution

The Bad

A FMO should be done to set the positive threshold

The Bottom Line

This conjugate works best for me. Other fluorochromes are too dim or do not work.

Share your experience with other scientists. Write a Review! »

Join the discussion